| CEO to Showcase Company's Latest Advances in Spinal Cord Injury Treatment at 8 Annual Event in New York InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV ), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds will present recent updates and meet one-on-one with investors during the Lazard Capital Markets 8 th Annual Healthcare Conference November 15-16 at The Pierre Hotel in New York City. Reynolds will present ...continued NVIV |
Friday, November 4, 2011
InVivo Therapeutics to Present at Lazard Capital Markets Healthcare Conference
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment